Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis-Reference-Cited by-同舟云学术

Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis

Published:2024-01 Issue:1 Volume:4 Page:100340
ISSN:2666-9145
Container-title:Ophthalmology Science
language:en
Short-container-title:Ophthalmology Science

Author:

Patra VijayKumar^ORCID,Woltsche Nora^ORCID,Cerpes Urban^ORCID,Bokanovic Danijela,Repelnig Maria,Joshi Aaroh,Perchthaler Isabella,Fischl Manuela^ORCID,Vocanson Marc,Bordag Natalie^ORCID,Durdevic Marija,Woltsche Johannes,Quehenberger Franz^ORCID,Legat Franz,Wedrich Andreas^ORCID,Horwath-Winter Jutta,Wolf Peter^ORCID

Funder

Bundesministerium für Wissenschaft, Forschung und Wirtschaft

Eli Lilly and Company

Medical University of Graz

Cilag

Austrian Science Fund

Publisher

Elsevier BV

Subject

Ophthalmology

Reference49 articles.

1. Atopic dermatitis;Weidinger;Lancet,2016

2. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis;Simpson;N Engl J Med,2016

3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial;Blauvelt;Lancet,2017

4. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome;Clinical Reviews in Allergy & Immunology;2024-07-02

2. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model;Frontiers in Immunology;2024-04-05

3. Okuläre Nebenwirkungen von Dupilumab – Übersichtsarbeit und Therapieempfehlung der „Kommission für Trockenes Auge und Oberflächenerkrankungen“ der Österreichischen Ophthalmologischen Gesellschaft (ÖOG);Spektrum der Augenheilkunde;2023-09-12